Other reports have indicated that specific chemotherapeutic agents, such as fluorouracil, bleomycin, asparaginase, fludarabine, and gemcitabine, were associated with the risk of PJP development3,27,28,32. This evidence concerns the gene ASPG and pneumocystosis.